Scancell Holdings plc (LON:SCLP - Get Free Report)'s stock price passed above its 50-day moving average during trading on Wednesday . The stock has a 50-day moving average of GBX 9.93 ($0.14) and traded as high as GBX 9.95 ($0.14). Scancell shares last traded at GBX 9.37 ($0.13), with a volume of 241,747 shares trading hands.
Scancell Price Performance
The company has a 50 day moving average of GBX 9.88 and a 200 day moving average of GBX 9.49. The company has a debt-to-equity ratio of -566.79, a quick ratio of 13.01 and a current ratio of 3.42. The stock has a market capitalization of £100.98 million, a price-to-earnings ratio of -14.95 and a beta of 0.35.
Insider Activity at Scancell
In other news, insider Martin Diggle bought 44,944 shares of Scancell stock in a transaction that occurred on Tuesday, May 20th. The shares were purchased at an average price of GBX 9 ($0.12) per share, with a total value of £4,044.96 ($5,523.64). Corporate insiders own 4.96% of the company's stock.
Scancell Company Profile
(
Get Free Report)
Scancell LSE: SCLP is a clinical stage immunotherapy biotech company developing treatments for significant unmet needs in cancer. We aim to translate our innovation and creativity into increased and durable responses in patients without compromising safety, addressing hard-to-treat cancers.
Scancell has developed a pipeline of ‘off-the-shelf' vaccines to induce immune responses and highly tumour specific monoclonal antibodies to redirect immune cells or drugs.
Read More
Before you consider Scancell, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Scancell wasn't on the list.
While Scancell currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
